On June 6th, the Chinese herbal medicine index was 2,098 points, a decrease of 10 points from yesterday, a decrease of 25.02% from the highest point of 2,798 points in the cycle (2023-08-10), and an increase of 115.18% from the lowest point of 975 points on November 25th, 2019. (Note: The cycle refers to June 30, 2019 to present)

According to the price monitoring of SunSirs, in the 23rd week of 2024 (6.03-6.07), there were 0 rising and 4 falling products on the price list of Chinese medicinal materials, and 4 products with zero rise and fall. The main commodities falling include Angelica (-1.72%), Astragalus membranaceus (-0.84%), Codonopsis pilosula (-0.72%).

According to the monitoring of the commodity market analysis system of the SunSirs, there have been merchants searching for goods in the market recently, and the bulk sales of goods have been smooth, with little change in the market. Currently, the price for 120 units of Sanchi in the market is 145 RMB/kg, 60 units are priced at 160-165 RMB/kg, and 40 units are priced around 170-175 RMB/kg.

Recently, some merchants in the production area of Panax notoginseng in Wenshan, Yunnan Province have been actively searching for goods, with an increase in trading volume compared to the previous period, which has led to a slight increase in prices. Holders of the goods have a strong willingness to sell. Due to differences in quality and cleanliness, the current price for 20 heads of Panax notoginseng with hats is 230 RMB, the cutting price is 220-230 RMB/kg, the 40 head price is 165 RMB/kg, the 60 head price is 144-150 RMB/kg, the 120 head price is 130-140 RMB/kg, the total root price is 104-110 RMB/kg, and the cutting price is 80-90 RMB/kg; Freeze dried Panax notoginseng is currently priced at around 280-300 RMB/kg for first grade goods (about 20 pieces are sun dried, with about 60 pieces per kilogram).

Due to the previous increase in red seed prices and drought, as well as the continued low prices of Panax notoginseng products, the production of Panax notoginseng may continue to decline. At the same time, starting from 2023, with the promotion of consistency evaluation of traditional Chinese medicine, the sales volume of Panax notoginseng injections such as Xuesaitong and Xueshuantong will strongly rebound, and the demand for raw materials will increase. This week, some businesses in Yunnan production area actively searched for goods, but overheating production in the early stage caused a huge inventory of Panax notoginseng. SunSirs analysis suggests that the price of Panax notoginseng may still remain strong in the short term, and the future market still needs to see the purchasing situation.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.